Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Benke, Geza; Turner, Michelle C.; Fleming, Sarah et al.
Occupational solvent exposure and risk of glioma in the INTEROCC studyBRITISH JOURNAL OF CANCER. Bd. 117. H. 8. 2017 S. 1246-1254
Klar, Ernst; Buechler, Markus W.; Lang, Hauke et al.
Oligometastases of Gastrointestinal Cancer OriginVISCERAL MEDICINE. Bd. 33. H. 1. 2017 S. 76-81
Renovanz, M.; Maurer, D.; Lahr, H. et al.
OPTIMIZING THE ASSESSMENT OF PSYCHOSOCIAL SUPPORT AND UNMET NEEDS IN GLIOMA PATIENTS AND THEIR CAREGIVERS IN CLINICAL PRACTICE - FIRST RESULTS OF THE OBSERVATIONAL PROSPECTIVE "ERASMUS" STUDYNEURO-ONCOLOGY. Bd. 19. 2017 S. 9-9
Wolff, Ingmar; Scavuzzo, Anna; Capitanio, Umberto et al.
Organ Preservation Is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma-Results of a Comprehensive Multicenter StudyUROLOGY. Bd. 109. 2017 S. 107-114
Wagener, Nina; Edelmann, Dominic; Benner, Axel et al.
Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic diseasePLOS ONE. Bd. 12. H. 9. 2017
Rule, Simon; Dreyling, Martin; Goy, Andre et al.
Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studiesBRITISH JOURNAL OF HAEMATOLOGY. Bd. 179. H. 3. 2017 S. 430-438
Woerns, M. -A.; Finn, R. S.; Merle, P. et al.
Outcomes with sorafenib (SOR) followed by regorafenib (REG) or placebo (PBO) for hepatocellular carcinoma (HCC): results of the international, randomized phase 3 RESORCE trialONCOLOGY RESEARCH AND TREATMENT. Bd. 40. 2017 S. 161-161
Makris, G. M.; Chrelias, C.; Papanota, A. et al.
Ovarian tumors: Should the cervix be examined first?EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY. Bd. 38. H. 3. 2017 S. 462-464
Finn, Richard S.; Crown, John; Lang, Istvan et al.
Overall survival results from the randomized phase II study of palbociclib (P) in combination with letrozole (L) vs letrozole alone for frontline treatment of ER+/HER2-advanced breast cancer (PALOMA-1; TRIO-18).JOURNAL OF CLINICAL ONCOLOGY. Bd. 35. 2017
Ishibashi, Kei; Haber, Tobias; Breuksch, Ines et al.
Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockadeONCOTARGET. Bd. 8. H. 33. 2017 S. 55230-55245